Volume 14, Issue 9, Pages (August 2013)

Slides:

Advertisements

Similar presentations

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)

Advertisements

Volume 14, Issue 12, Pages (November 2013)

Volume 370, Issue 9586, Pages (August 2007)

Volume 14, Issue 4, Pages (April 2013)

Volume 386, Issue 10006, Pages (November 2015)

Volume 12, Issue 9, Pages (September 2011)

Su K. Metcalfe, MD, MPH, Michael T

Volume 364, Issue 9440, Pages (September 2004)

Volume 17, Issue 12, Pages (December 2016)

Volume 16, Issue 2, Pages (February 2015)

Volume 357, Issue 9257, Pages (March 2001)

Volume 12, Issue 11, Pages (October 2011)

Volume 376, Issue 9747, Pages (October 2010)

Volume 388, Issue 10058, Pages (November 2016)

Volume 15, Issue 6, Pages (May 2014)

Erlotinib or Docetaxel for Second-Line Treatment of Non-small Cell Lung Cancer: A Real-World Cost-Effectiveness Analysis Ian Cromwell, MSc, Kimberly.

Volume 378, Issue 9809, Pages (December 2011)

Volume 14, Issue 4, Pages (April 2013)

Volume 13, Issue 12, Pages (December 2012)

Volume 373, Issue 9666, Pages (March 2009)

Volume 355, Issue 9204, Pages (February 2000)

Volume 9, Issue 5, Pages (May 2008)

Volume 16, Issue 8, Pages (August 2015)

Volume 15, Issue 4, Pages (April 2014)

Volume 1, Issue 3, Pages (August 2014)

Volume 15, Issue 4, Pages (April 2014)

Volume 66, Issue 2, Pages (August 2014)

Aspirin in the prevention of cancer – Author's reply

Phase I Trial of Cediranib in Combination with Cisplatin and Pemetrexed in Chemonaive Patients with Unresectable Malignant Pleural Mesothelioma (SWOG.

Volume 15, Issue 4, Pages (April 2014)

Susan C. Scott, MD, Nathan A. Pennell, MD, PhD

Volume 366, Issue 9484, Pages (August 2005)

Endpoints in Phase II Trials for Advanced Non-small Cell Lung Cancer

Volume 14, Issue 8, Pages (July 2013)

Relationship between Overall Survival and Response or Progression-Free Survival in Advanced Non–Small Cell Lung Cancer Patients Treated with Anti–PD-1/PD-L1.

Volume 14, Issue 8, Pages (July 2013)

Volume 379, Issue 9812, Pages (January 2012)

Volume 15, Issue 1, Pages (January 2014)

Volume 13, Issue 12, Pages (December 2012)

Phase II Trial of Carboplatin, Paclitaxel, Cetuximab, and Bevacizumab Followed by Cetuximab and Bevacizumab in Advanced Nonsquamous Non–Small-Cell Lung.

Bortezomib (PS-341) in Relapsed or Refractory Extensive Stage Small Cell Lung Cancer: A Southwest Oncology Group Phase II Trial (S0327) Primo N. Lara,

Volume 6, Issue 6, Pages (June 2005)

Volume 14, Issue 11, Pages (October 2013)

Relevance of Platinum-Sensitivity Status in Relapsed/Refractory Extensive-Stage Small- Cell Lung Cancer in the Modern Era: A Patient-Level Analysis of.

Volume 385, Issue 9962, Pages (January 2015)

Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled,

Volume 15, Issue 8, Pages (July 2014)

Volume 388, Issue 10058, Pages (November 2016)

Randomized Phase III Trial of Docetaxel Plus Carboplatin with or without Levofloxacin Prophylaxis in Elderly Patients with Advanced Non-small Cell Lung.

Volume 15, Issue 6, Pages (May 2014)

Volume 5, Issue 4, Pages (April 2018)

Volume 16, Issue 8, Pages (August 2015)

Volume 378, Issue 9809, Pages (December 2011)

Volume 14, Issue 8, Pages (July 2013)

Volume 373, Issue 9658, Pages (January 2009)

Volume 375, Issue 9714, Pages (February 2010)

Volume 15, Issue 6, Pages (May 2014)

Volume 15, Issue 1, Pages (January 2014)

Volume 12, Issue 8, Pages (August 2013)

ACST: which subgroups will benefit most from carotid endarterectomy?

Volume 375, Issue 9715, Pages (February 2010)

A Phase 2 Randomized Trial of Paclitaxel and Carboplatin with or without Panitumumab for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer

Volume 376, Issue 9747, Pages (October 2010)

Volume 13, Issue 7, Pages (July 2014)

DHA-Paclitaxel (Taxoprexin) as First-Line Treatment in Patients with Stage IIIB or IV Non-small Cell Lung Cancer: Report of a Phase II Open-Label Multicenter.

Volume 13, Issue 5, Pages (May 2012)

Pulmonary Resection for Metastases from Colorectal Cancer

SWOG S0709: Randomized Phase II Trial of Erlotinib versus Erlotinib Plus Carboplatin/Paclitaxel in Patients with Advanced Non–Small Cell Lung Cancer and.

Volume 14, Issue 7, Pages (June 2013)

Bortezomib Plus Gemcitabine/Carboplatin as First-Line Treatment of Advanced Non- small Cell Lung Cancer: A Phase II Southwest Oncology Group Study (S0339)

Presentation transcript:

Volume 14, Issue 9, Pages 893-900 (August 2013) Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial Dr David I Quinn, FRACP, Catherine M Tangen, DrPH, Prof Maha Hussain, MD, Prof Primo N Lara, MD, Amir Goldkorn, MD, Carol M Moinpour, PhD, Mark G Garzotto, MD, Philip C Mack, PhD, Prof Michael A Carducci, MD, J Paul Monk, MD, Przemyslaw W Twardowski, Peter J Van Veldhuizen, MD, Neeraj Agarwal, MD, Prof Celestia S Higano, MD, Nicholas J Vogelzang, MD, Prof Ian M Thompson, MD The Lancet Oncology Volume 14, Issue 9, Pages 893-900 (August 2013) DOI: 10.1016/S1470-2045(13)70294-8 Copyright © 2013 Elsevier Ltd Terms and Conditions

Figure 1 Trial profile The Lancet Oncology 2013 14, 893-900DOI: (10.1016/S1470-2045(13)70294-8) Copyright © 2013 Elsevier Ltd Terms and Conditions

Figure 2 Kaplan-Meier curves of composite progression-free survival The Lancet Oncology 2013 14, 893-900DOI: (10.1016/S1470-2045(13)70294-8) Copyright © 2013 Elsevier Ltd Terms and Conditions

Figure 3 Kaplan-Meier curves of overall survival The Lancet Oncology 2013 14, 893-900DOI: (10.1016/S1470-2045(13)70294-8) Copyright © 2013 Elsevier Ltd Terms and Conditions